691 - 700 of 982 Results

  • This Week in Coronavirus: January 29 to February 4

    Policy Watch

    During the 54th week since the first coronavirus case appeared in the United States, the world is at nearly 105 million COVID-19 cases. The U.S. approached 26.7 million cases and a total of 455,900 deaths.

  • KFF/UNAIDS Analysis Finds That While Donor Government Spending on HIV Increased in 2020, Future Funding is Uncertain with COVID-19 Challenges

    News Release

    A new report from KFF (Kaiser Family Foundation) and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that donor government disbursements to combat HIV in low- and middle-income countries increased by US$377 million in 2020, reaching US$8.2 billion in 2020 compared to US$7.8 billion in 2019. Donor government funding supports HIV care and treatment, prevention, and other services in low- and middle-income countries. The rise in funding is almost entirely the result of an…

  • COVAX and the United States

    Issue Brief

    This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX's organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

  • Simulating the Impact of the Drug Price Negotiation Proposal in the Build Back Better Act

    Issue Brief

    The Build Back Better Act (BBBA) includes a range of health and other proposals supported by President Biden, including a proposal to allow the federal government to negotiate the price of some prescription drugs covered under Medicare Part B (administered by physicians) and Medicare Part D (retail outpatient drugs). This brief illustrates the potential scope of the drug price negotiation proposal in the BBBA. This analysis is designed to highlight the types of Medicare-covered drugs…

  • This Week in Coronavirus: January 22 to January 28

    Policy Watch

    During the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.

  • Mental Health Impact of the COVID-19 Pandemic: An Update

    Poll Finding

    The latest KFF COVID-19 Vaccine Monitor finds that those hardest hit by the mental health impacts of the coronavirus pandemic have been younger people and women, including mothers. This analysis of polling data explores who has been hardest hit by mental health impacts of the COVID-19 pandemic, how experience with COVID-19 related death and worry about getting sick impact mental health. It also explores problems with access to mental health care and treatment during the…

  • This Week in Coronavirus: January 15 to January 21

    Policy Watch

    During the 52nd week since the first coronavirus case appeared in the United States, the U.S. surpassed 24.6 million total cases and 410,100 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.

  • Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping

    Policy Watch

    This analysis compares trends in new COVID-19 cases and deaths among nursing facility residents with trends in all other new COVID-19 cases and deaths excluding nursing facility residents through February 7, 2021. This analysis shows a marked divergence in new cases and deaths per week between nursing facility residents and the rest of the US population since December 2020. This drop in new deaths and cases in nursing facility residents coincides with the start of…

  • Key Issues and Questions for PEPFAR’s Future

    Issue Brief

    This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.